Assessment of bone health in breast cancer patients starting adjuvant aromatase inhibitors: A quality improvement clinical audit

INTRODUCTION: Adjuvant Aromatase Inhibitors (AIs) predispose breast cancer patients to accelerated bone loss. Guidelines recommend initial screening and follow up of bone mineral density with dual energy X-ray absorptiometry (DEXA) scan. In this audit we assessed the rate of adherence to these guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zekri, Jamal, Farag, Kamel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154697/
https://www.ncbi.nlm.nih.gov/pubmed/28008376
http://dx.doi.org/10.1016/j.jbo.2016.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154697/
https://www.ncbi.nlm.nih.gov/pubmed/28008376
http://dx.doi.org/10.1016/j.jbo.2016.05.007

Ejemplares similares